China Care Atlas logo
China Care Atlas
  • Home
  • Hospitals
  • Treatments
  • Build My Plan
  • Guides
China Care Atlas logo
China Care Atlas

Compare top hospitals, advanced treatments, and transparent medical tourism information for China before you book travel.

Quick Links
HospitalsTreatmentsBuild My PlanGuides
Advanced Treatments
CAR-T & Cell TherapyProton & Heavy IonCardiovascular SurgeryComplex Neurosurgery
Legal
AboutContactHow We ResearchPrivacy PolicyTerms

2026 China Care Atlas. Advanced, Transparent Healthcare in China.

Hospital specialists reviewing a treatment plan in China
SPECIALTY & TREATMENT DIRECTORY

Specialties & Treatments in China

45Fudan specialty rankings loaded5Major Treatment Directions26Treatment pathways reviewedEditorial research desk · independent

Research-stage dataset · status research only · intake details needs direct confirmation · directions reviewed 18 August 2026. Not a clinical recommendation; confirm eligibility and access directly with the hospital.

Popular:
Research-stage hospital & therapy matrix

Advanced Treatment Pathways & Hospital Centers

Research notes on Chinese tertiary centers, advanced modalities (CAR-T, particle therapy, robotic surgery, organ transplant), target indications, and international patient access routes. Capability notes are starting points for direct confirmation, not a referral or acceptance decision.

Dataset status research only·intake release needs direct confirmation·reviewed 18 August 2026

Clinical Desk 05复杂心血管疾病Research review · needs direct confirmation

Complex cardiovascular diseases

World-leading cardiovascular surgical and interventional programs for complex aortic emergencies, structural heart valve disease, total coronary occlusions, and advanced heart failure.

Explore Full Guide & Hospitals

Leading Hospital Centers & Specific Treatments Offered

Research notes on Chinese tertiary hospitals, specific advanced modalities, target indications, and international patient pathways

2 hospitals profiled
Directory cross-check0 of 4 candidates in our hospital directory4 not yet listed
  • Fuwai Hospitalnot in our hospital directory
  • Shanghai Children's Medical Centernot in our hospital directory
  • Shanghai DeltaHealth Hospitalnot in our hospital directory
  • Shanghai East Hospitalnot in our hospital directory

A missing entry means our hospital directory does not cover that facility yet; it is not a statement about the facility's clinical capability.

Fuwai Hospital (中国医学科学院阜外医院)
BeijingGrade 3A Public · National Center for Cardiovascular Diseases
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantGlobal Pioneer Benchmark
Sun's Procedure (Total Arch Replacement + Frozen Elephant Trunk)
Target Indication:

Acute and chronic Stanford Type A aortic dissection, complex aortic arch aneurysms

Clinical Feature: Invented at Fuwai; eliminates false lumen in downstream thoracic aorta; proven long-term durability in >10,000 cases.

Minimally Invasive InterventionalNMPA Approved Commercial
Fully Magnetically Levitated LVAD Implantation (Corheart 6 / HeartCon)
Target Indication:

End-stage heart failure, refractory dilated cardiomyopathy

Clinical Feature: Ultra-compact 90g pump; minimal shear stress reducing hemolysis and bleeding events; destination therapy.

International Patient Access:

International Medical Services coordinates case evaluation, English diagnostic review, and planned elective inpatient admission.

Pre-Travel Candidacy Note:

Direct patient intake for complex elective surgeries. Requires comprehensive cardiac CTA and echocardiography before travel.

Shanghai DeltaHealth Hospital (上海德达医院)
ShanghaiInternational Specialized Cardiovascular Hospital
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantRoutine Clinical Center
Minimally Invasive Aortic Arch Surgery & Hybrid Stenting
Target Indication:

Thoracoabdominal aortic aneurysms, Stanford Type B complicated dissection, arch pathologies

Clinical Feature: Hybrid theater debranching techniques reducing cardiopulmonary bypass time; rapid post-op extubation.

Minimally Invasive InterventionalRoutine Clinical Center
Transcatheter Valve Repair & Replacement (TAVR / MitraClip)
Target Indication:

Aortic stenosis, severe mitral regurgitation in high-risk patients

Clinical Feature: Full-time international Heart Team, commercial insurance direct billing, bedside bilingual nursing.

International Patient Access:

Dedicated international appointment desk (+86 4008 210 277 / appointment@deltahealth.com.cn) with global insurance direct billing.

Pre-Travel Candidacy Note:

Active intake for domestic and overseas cardiovascular patients. Fast-track second opinion and surgical scheduling.

Cross-Specialty Collaboration Route:
Primary: Cardiovascular medicineCardiac surgeryUltrasound medicineAnesthesiologyCritical care medicineRadiology

Target Disease Indications & Qualified Hospital Finder (4)

Which Chinese tertiary hospitals are noted for the beds, ICU support, and technologies each condition typically needs

4 target conditions
High-Priority Target#01
Stanford Type A Aortic Dissection & Arch Aneurysms (Stanford A型主动脉夹层与主动脉弓部动脉瘤)

Target Stage & Goal: Tear or dilation involving the ascending aorta and aortic arch threatening rupture or coronary/cerebral malperfusion.

Hospitals noted for treating this condition (confirm eligibility directly):
Fuwai Hospital, CAMS & PUMC (中国医学科学院阜外医院)
Beijing · National Center for Cardiovascular Diseases (World Authority on Aortic Surgery)
Department of Vascular Surgery / International Medical Department
Hospital Facilities & Qualified Conditions:

Birthplace and global training authority for Sun's Procedure; 24/7 dedicated aortic emergency surgical team; state-of-the-art hybrid operating rooms with modern cardiopulmonary bypass (CPB) and selective cerebral perfusion.

Specific Treatment & Technology Offered:

Sun's Procedure (Total Aortic Arch Replacement with Frozen Elephant Trunk / 孙氏手术: 升主动脉置换+全主动脉弓替换+冷冻支架象鼻术).

Required Patient Eligibility Criteria:

CTA confirmed Acute or Subacute Stanford Type A dissection, or aortic arch aneurysm involving vital supra-aortic branches; patient hemodynamically stable or prepared for emergency surgical transfer.

Shanghai DeltaHealth Hospital (上海德达医院)
Shanghai · Specialized Cardiovascular Hospital (Partnered with Columbia HeartSource)
Heart Team International Clinic
Hospital Facilities & Qualified Conditions:

Headed by national leading thoracic aortic surgical masters, state-of-the-art hybrid vascular operating theaters, dedicated 20-bed cardiovascular surgical ICU, English-speaking clinical concierge.

Specific Treatment & Technology Offered:

Minimally Invasive Hybrid Aortic Arch Debranching & Frozen Elephant Trunk Stenting.

Required Patient Eligibility Criteria:

International or domestic patients seeking elective or urgent aortic arch reconstruction; stable peripheral organ perfusion.

High-Priority Target#02
Severe Calcified Aortic Stenosis & Complex Valvular Disease (重度钙化性主动脉瓣狭窄与复杂瓣膜病)

Target Stage & Goal: Severe symptomatic aortic stenosis with heavy calcification, bicuspid morphology, or severe functional mitral/tricuspid regurgitation in high-risk surgical patients.

Hospitals noted for treating this condition (confirm eligibility directly):
Zhongshan Hospital, Fudan University (复旦大学附属中山医院)
Shanghai · National Pioneer in Structural Heart Disease
Department of Cardiology / Structural Heart Disease Program
Hospital Facilities & Qualified Conditions:

National pioneer center for transcatheter structural heart interventions; multi-detector CT valvular reconstruction laboratory; 3D transesophageal echocardiography (TEE) guided cath labs; ECMO emergency backup.

Specific Treatment & Technology Offered:

Transcatheter Aortic Valve Replacement (TAVR - specialized self-expanding and balloon-expandable valves tailored for heavy bicuspid calcification) & Transcatheter Edge-to-Edge Repair (TEER / MitraClip / DragonFly).

Required Patient Eligibility Criteria:

Severe symptomatic aortic stenosis (AVA <1.0 cm², mean gradient >40 mmHg) or severe mitral regurgitation (grade 3-4+); STS surgical risk score >8% or anatomical contraindication to open surgery; suitable femoral vascular anatomy.

Fuwai Hospital (北京阜外医院)
Beijing · National Reference Center for Valve Surgery
Cardiac Surgery Department
Hospital Facilities & Qualified Conditions:

National reference center performing >3,000 surgical valve procedures annually; thoracoscopic minimally invasive cardiac surgery suites.

Specific Treatment & Technology Offered:

Thoracoscopic Minimally Invasive Valve Repair / Bioprosthetic Replacement & Sutureless Valve Implantation.

Required Patient Eligibility Criteria:

Multivalvular disease, complex infective endocarditis, or rheumatic destruction; LVEF ≥30%.

Specialized Indication#03
End-Stage Heart Failure & Dilated Cardiomyopathy (终末期心力衰竭与扩张型心肌病)

Target Stage & Goal: Refractory NYHA Class IV heart failure despite maximal medical therapy requiring permanent mechanical circulatory support or bridge-to-transplant.

Hospitals noted for treating this condition (confirm eligibility directly):
Fuwai Hospital (阜外医院)
Beijing · National Center for Cardiovascular Diseases
Heart Failure & Transplant Center
Hospital Facilities & Qualified Conditions:

National Heart Failure Clinical Medical Center, designated national ventricular assist device evaluation lead institution, dedicated mechanical circulatory support (MCS) intensive care unit.

Specific Treatment & Technology Offered:

Third-Generation Fully Magnetic Levitation Left Ventricular Assist Device (LVAD - Corheart 6 / HeartCon "Rocket Heart") Implantation as destination therapy or bridge-to-transplant.

Required Patient Eligibility Criteria:

NYHA Class IV heart failure despite optimal guideline-directed medical therapy; LVEF <25%; INTERMACS profile 2-4; absence of irreversible severe right ventricular failure or severe coagulation defects.

Specialized Indication#04
Complex Coronary Chronic Total Occlusion (CTO) & Left Main Disease (复杂冠脉慢性完全闭塞CTO与左主干病变)

Target Stage & Goal: Multi-vessel coronary artery disease with long-segment calcified chronic total occlusions refractory to standard catheterization.

Hospitals noted for treating this condition (confirm eligibility directly):
Fuwai Hospital & Zhongshan Hospital
Beijing / Shanghai · National Cardiovascular Benchmarks
Interventional Cardiology Division
Hospital Facilities & Qualified Conditions:

International training centers for complex CTO interventions; high-resolution intravascular ultrasound (IVUS), optical coherence tomography (OCT), intravascular lithotripsy (IVL 震波碎石) and coronary rotablation platforms; Impella percutaneous LVAD support.

Specific Treatment & Technology Offered:

Antegrade/Retrograde Wire Escalation CTO-PCI & Off-Pump Coronary Artery Bypass Grafting (OPCAB 心脏不停跳冠脉搭桥).

Required Patient Eligibility Criteria:

Severe refractory angina, documented myocardial ischemia; complex multi-vessel CAD; SYNTAX score >32 (evaluated by multidisciplinary Heart Team).

Records Needed Before Clinical Review (5)

  • ✓Full-body Aorta / Coronary Computed Tomography Angiography (CTA) with 3D reconstructions (DICOM discs)
  • ✓Transthoracic and transesophageal echocardiography reports and digital loops (EF, valve gradients, regurgitant volumes)
  • ✓Recent coronary angiogram catheterization reports and video files (if previous cath was performed)
  • ✓Baseline organ function tests: Serum creatinine, liver enzymes, coagulation profile, and complete blood count
  • ✓Recent ECG and 24-hour Holter monitoring reports (if arrhythmia is present)

Practical Pathway Financial Scope (4 stages)

Where expenses occur across the pathway · figures are published reference ranges
Stage 1: Preoperative Cardiovascular Evaluation & Imaging (术前心血管评估与多排CTA)

Scope: Comprehensive CTA re-evaluation, multi-view echocardiography, coronary angiogram if indicated, and Heart Team surgical risk scoring.

Financial Notes: Completed within 2-3 days of admission to determine precise surgical vs interventional approach.

Stage 2: Surgical Procedure / Device Implantation (手术施术与耗材植入)

Scope: Open cardiovascular surgery under cardiopulmonary bypass or cath-lab interventional implantation, including prostheses (frozen elephant trunk stent, TAVR valve, or LVAD pump).

Financial Notes: Hardware and device costs are significant (e.g. TAVR valve approx. 180,000 - 250,000 RMB, LVAD pump device approx. 600,000 - 800,000 RMB).

Published reference range · noted 2026-08-18 · confirm current price

Stage 3: Cardiac Intensive Care (CICU) & Hemodynamic Recovery (重症CICU监护与机械循环)

Scope: Postoperative mechanical ventilation, inotrope titration, continuous cardiac output monitoring, ECMO/IABP standby if needed, and chest tube management.

Financial Notes: Length of CICU stay varies (typically 2-5 days for uncomplicated cases, longer if severe pulmonary or renal backup needed).

Stage 4: Step-Down Ward Rehabilitation & Anticoagulation Stabilization (普通病房康复与抗凝)

Scope: Cardiac rehabilitation mobilization, warfarin/NOAC international normalized ratio (INR) stabilization, repeat echo verification, and discharge planning.

Financial Notes: Prepares patient for commercial flight fitness (typically requires 14-21 days total post-op before long-distance air travel).

Published reference ranges noted 2026-08-18; they are not a quote. Confirm the current itemized price and payment terms directly with the hospital before budgeting or travel.

Budgeting & Cost Scope Notice:

Device choices (imported vs domestic valves/implants), surgical complications, need for prolonged dialysis or ECMO support will directly affect the total bill.

Published intake contacts — confirm before use
needs direct confirmation

These numbers and addresses are published references captured 2026-08-18. They have not been reconfirmed for this case — call or email the hospital yourself to confirm the channel is still open, who answers, and what they need before you send records. Published intake references captured on the date shown. They were not re-confirmed by phone or email on this page, and individual hospitals can change or limit international patient channels.

Pre-Travel Clinical Intake Advisory

Current international intake, elective-case boundaries, implant and ICU costs, flight fitness, anticoagulation, and post-discharge care

Advanced Clinical Research

Priority Treatment Directions

Dedicated clinical desks for complex, refractory, and rare conditions in China.

Desk 01血液肿瘤与细胞治疗

Hematologic cancers & cell therapy

Blood cancers, transplantation, and indication-specific cell therapies.

Priority Pathways

Relapsed or refractory multiple myelomaRelapsed or refractory large B-cell lymphomaAcute lymphoblastic leukemia

Key Centers

  • Ruijin Hospitalnot in our hospital directory
  • Shanghai SinoUnited Hospitalnot in our hospital directory
Explore Research Desk
Desk 02复杂或复发肿瘤

Complex or recurrent cancers

Multidisciplinary options for recurrent, refractory, or technically difficult tumors.

Priority Pathways

Recurrent nasopharyngeal and complex head-and-neck cancersRefractory or recurrent brain tumorsAdvanced CLDN18.2-positive gastric or gastroesophageal junction cancer

Key Centers

  • Shanghai Proton and Heavy Ion Centernot in our hospital directory
  • Fudan University Shanghai Cancer Centernot in our hospital directory
Explore Research Desk
Desk 03儿童复杂与罕见病

Pediatric complex & rare diseases

Specialist children’s hospitals for oncology, congenital disease, and rare-disease review.

Priority Pathways

Pediatric leukemia, lymphoma, and solid tumorsComplex congenital heart diseaseGenetic, metabolic, and undiagnosed rare diseases

Key Centers

  • Shanghai Children's Medical Centernot in our hospital directory
  • Children's Hospital of Fudan Universitynot in our hospital directory
Explore Research Desk
Desk 04复杂神经疾病

Complex neurological diseases

Neurosurgery, epilepsy, movement disorders, and coordinated rehabilitation.

Priority Pathways

Complex brain tumorsCerebrovascular malformations and complex cerebrovascular diseaseDrug-resistant epilepsy

Key Centers

  • Beijing Tiantan Hospitalnot in our hospital directory
  • Huashan Hospitalnot in our hospital directory
Explore Research Desk
Desk 05复杂心血管疾病

Complex cardiovascular diseases

Aortic, structural, congenital, and inherited heart-disease programs.

Priority Pathways

Aortic dissection and complex aortic diseaseAdult complex congenital heart diseasePediatric complex congenital heart disease

Key Centers

  • Fuwai Hospitalnot in our hospital directory
  • Shanghai Children's Medical Centernot in our hospital directory
Explore Research Desk

How to use this directory

Rankings as a Starting Guide

Use rankings to shortlist top departments, then verify international access and care fit.

  1. 01

    Choose the specialty first

    Start with the department that treats your condition, not the best-known hospital name.

  2. 02

    Align department strengths with access

    Review specialized clinical teams, English medical services, and admission channels alongside hospital reputation.

  3. 03

    Prepare structured clinical documentation

    Compile standardized diagnostic summaries, scans, and clinical histories to facilitate direct hospital evaluation.

Continue with a specific case

Build Your Care Pathway

Organize medical records, confirm hospital fit, and plan next steps before traveling.

Build a personalized care plan

1. Confirm the department route

Check that the named department, not only the hospital, can review the condition you are researching.

2. Prepare a usable record set

Bring translated summaries, imaging, pathology, treatment history, and a concise clinical question.

3. Confirm access before travel

Ask the hospital about appointment timing, record submission, language support, payment, and follow-up needs.

Next step

Choose your next step

Explore accredited public hospitals with dedicated international patient departments, or generate an individualized travel plan.

Explore Top HospitalsBuild My Plan